主要成分含量为0！推脱责任、涉嫌故意造假，同仁堂被约谈

Core Viewpoint - The Shanghai Consumer Protection Committee has raised concerns regarding the authenticity of Antarctic krill oil products marketed by Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd, leading to an investigation and potential legal actions against the involved parties [4][5][9]. Group 1: Product Issues - A product labeled as "99% high-purity Antarctic krill oil" was found to have a phospholipid content of 0%, despite claims of 43% on its packaging [4][5]. - The product's marketing included misleading statements such as "high content," "imported from Chile," and "highly purified," which were proven to be false [5]. Group 2: Company Accountability - Anhui Hab Pharmaceutical Co., Ltd, the manufacturer, admitted that the product did not contain the claimed Antarctic krill oil during production [4][5]. - Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd, the distributor, denied knowledge of the alleged fraudulent activities and attempted to deflect responsibility [4][5]. Group 3: Regulatory Actions - The Shanghai Consumer Protection Committee has urged the distributor to conduct a self-examination, inform consumers of the situation, issue an apology, and recall the problematic products [5]. - The committee has also notified relevant regulatory authorities in Sichuan to monitor the situation [5]. Group 4: Company Background - Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd was established in June 2000 and is a member of the Beijing Tongrentang Group, with a 51% stake held by Beijing Tongrentang Health Pharmaceutical Co., Ltd [7][8]. - The company has faced scrutiny in the past for similar issues, including false advertising related to fish oil products [10].